A detailed history of Vanguard Group Inc transactions in Vericel Corp stock. As of the latest transaction made, Vanguard Group Inc holds 3,483,896 shares of VCEL stock, worth $197 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,483,896
Previous 3,444,682 1.14%
Holding current value
$197 Million
Previous $158 Million 6.86%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$42.25 - $53.56 $1.66 Million - $2.1 Million
39,214 Added 1.14%
3,483,896 $147 Million
Q2 2024

Aug 13, 2024

BUY
$41.71 - $52.9 $1.3 Million - $1.65 Million
31,240 Added 0.92%
3,444,682 $158 Million
Q1 2024

May 10, 2024

BUY
$32.52 - $52.33 $1.28 Million - $2.06 Million
39,349 Added 1.17%
3,413,442 $178 Million
Q4 2023

Feb 14, 2024

BUY
$30.85 - $37.09 $1.5 Million - $1.8 Million
48,514 Added 1.46%
3,374,093 $120 Million
Q3 2023

Nov 14, 2023

SELL
$31.69 - $39.25 $118,425 - $146,677
-3,737 Reduced 0.11%
3,325,579 $111 Million
Q2 2023

Aug 14, 2023

SELL
$29.0 - $38.37 $477,804 - $632,184
-16,476 Reduced 0.49%
3,329,316 $125 Million
Q1 2023

May 15, 2023

BUY
$23.85 - $31.34 $903,056 - $1.19 Million
37,864 Added 1.14%
3,345,792 $98.1 Million
Q4 2022

Feb 10, 2023

BUY
$17.65 - $27.37 $1.3 Million - $2.02 Million
73,833 Added 2.28%
3,307,928 $87.1 Million
Q3 2022

Nov 14, 2022

BUY
$22.62 - $32.54 $2.01 Million - $2.89 Million
88,923 Added 2.83%
3,234,095 $75 Million
Q2 2022

Aug 12, 2022

BUY
$22.88 - $39.45 $3.22 Million - $5.55 Million
140,645 Added 4.68%
3,145,172 $79.2 Million
Q1 2022

May 13, 2022

SELL
$31.69 - $43.29 $1.41 Million - $1.93 Million
-44,536 Reduced 1.46%
3,004,527 $115 Million
Q4 2021

Feb 14, 2022

BUY
$35.2 - $52.6 $207,116 - $309,498
5,884 Added 0.19%
3,049,063 $120 Million
Q3 2021

Nov 12, 2021

BUY
$46.35 - $59.75 $583,361 - $752,013
12,586 Added 0.42%
3,043,179 $149 Million
Q2 2021

Aug 13, 2021

BUY
$47.2 - $67.81 $143 Million - $206 Million
3,030,593 New
3,030,593 $159 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.67B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.